Gregory L. Verdine

机构：Harvard University, BirdLife International, Acorn, Harvard Stem Cell Institute, FogPharma (United States) · ORCID：0000-0002-2195-364X

发表论文 324 篇 · 总被引 27297 次 · h-index 81

代表论文

• Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides (2017 · Nature Biotechnology · 被引 381)
• Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface (2020 · Proceedings of the National Academy of Sciences · 被引 86)
• Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins (2024 · Nature Communications · 被引 50)
• Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer (2017 · Nature Communications · 被引 50)
• The trajectory of intrahelical lesion recognition and extrusion by the human 8-oxoguanine DNA glycosylase (2020 · Nature Communications · 被引 45)
• Exceptionally high-affinity Ras binders that remodel its effector domain (2017 · Journal of Biological Chemistry · 被引 43)